Bronchial carcinoid tumors are uncommon, slow-growing neuroendocrine malignancies that primarily originate in the gastrointestinal tract or the lungs. Patients often experience respiratory issues like coughing or wheezing, but they may also develop carcinoid syndrome, a condition marked by skin flushing, diarrhea, and heart valve complications due to excessive serotonin production. To identify these growths, clinicians utilize CT scans, bronchoscopy, and urine tests to detect specific hormonal markers. On a microscopic level, these tumors are identified by rosette patterns and specific chemical stains like chromogranin A. Because these masses are frequently resistant to radiation and chemotherapy, the primary medical intervention is surgical removal. For those with persistent hormonal symptoms, medications such as octreotide are administered to inhibit secretion and improve the patient's quality of life.